Profile
GCTK ISRG BDXA BDX ALC RMD
Company Name GlucoTrack, Inc. Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company Alcon Inc. ResMed Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $3.65M $189.34B $55.91B $51.42B $37.61B $36.15B
Employees 0.01K 15.64K 0.00K 70.00K 25.60K 9.98K
CEO Paul V. Goode Gary S. Guthart - Thomas E. Polen Jr. David J. Endicott Michael J. Farrell BE, MBA, SM
Ratings
GCTK ISRG BDXA BDX ALC RMD
Quant Rating Score 3 3 5 3 3 3
Quant Rating Neutral Neutral Strong Buy Neutral Neutral Neutral
Trading
GCTK ISRG BDXA BDX ALC RMD
Last Close $6.47 $534.28 $59.24 $178.71 $73.89 $246.88
High 52 $10.59 $610.45 $59.24 $249.08 $98.3 $293.73
Low 52 $0.06 $429.59 $59.24 $165.15 $72.05 $204.58
Price vs. 52 Week High -38.9 % -12.48 % 0 % -28.25 % -24.83 % -15.95 %
Price vs. 52 Week Low 10683.3 % 24.37 % 0 % 8.21 % 2.55 % 20.68 %
Total Return
GCTK ISRG BDXA BDX ALC RMD
1 Month Return 0 % 21.97 % 0 % -6.41 % -1.54 % -8.8 %
3 Month Return 3.85 % 10.59 % 0 % 1.33 % -15.91 % -11.58 %
6 Month Return 3590.82 % 3.31 % 0 % 5.41 % -23.17 % 4.39 %
9 Month Return 10009.4 % -6.57 % 0 % -27.82 % -18.88 % 4.53 %
YTD Return 1634.58 % 2.36 % 0 % -21.23 % -12.96 % 7.95 %
1 Year Return 271.84 % 5.52 % 0 % -24.03 % -19.5 % 1.06 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
GCTK ISRG BDXA BDX ALC RMD
Dividend Yield Percentage (TTM) - - 2.32 % 2.32 % 0.44 % 0.89 %
Dividend Paid and Capex Coverage Ration (TTM) -341.05 % 4.3 % 1.73 % 1.73 % 3.26 % 4.31 %
Dividend Per Share (TTM) - - 4.16 % 4.16 % 0.33 % 2.19 %
Payout Ratio (TTM) - - 73.1 % 73.1 % 15.71 % 22.31 %
Profitability
GCTK ISRG BDXA BDX ALC RMD
Gross Profit Margin TTM -70.83 % 66.41 % 45.08 % 45.08 % 55.13 % 60.08 %
Return on Assets TTM -128.34 % 14.19 % 2.93 % 2.93 % 3.42 % 17.31 %
Return on Equity TTM 1817.48 % 16.08 % 6.31 % 6.31 % 4.93 % 25.13 %
Return on Capital Employed TTM -425.02 % 16.05 % 5.78 % 5.78 % 4.98 % 24.74 %
Net Income Per EBT TTM 100 % 86.77 % 83.91 % 83.91 % 85.57 % 82.6 %
EBT Per Ebit TTM 43.27 % 112.41 % 70.86 % 70.86 % 86.96 % 99.79 %
EBIT Per Revenue TTM -126179.17 % 29.3 % 12.63 % 12.63 % 14.38 % 33.18 %
Cash Flow To Debt Ratio TTM -5364.79 % - 16.82 % 16.82 % 39.27 % 222.53 %
Receivables Turnover TTM - 7.63 7.27 7.27 4.98 5.79
Payables Turnover TTM 0.02 11.09 1.85 1.85 5.03 7.87
Inventory Turnover TTM - 1.81 2.97 2.97 1.88 2.22
Fixed Asset Turnover TTM 18.05 % 186.61 % 313.67 % 313.67 % 197.54 % 724.52 %
Asset Turnover TTM 0.24 % 49.67 % 38.95 % 38.95 % 31.94 % 63.28 %
Operating Cash Flow Per Share TTM -28.97 8.3 11.3 11.3 4.16 12.86
Free Cash Flow Per Share TTM -29.05 6.37 8.85 8.85 3.23 12.06
Cash Per Share TTM 1932.24 % 1376.56 % 262.85 % 262.85 % 284.33 % 944.79 %
Operating Cash Flow Sales Ratio TTM -59683.33 % 30.8 % 15.22 % 15.22 % 20.57 % 35.82 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.29 % 76.72 % 78.37 % 78.37 % 77.51 % 93.83 %
Cash Flow Coverage Ratios TTM -5364.79 % - 16.82 % 16.82 % 39.27 % 222.53 %
Price To Free Cash Flows Ratio TTM -0.25 83.36 20.16 20.16 23.53 20.46
Price To Operating Cash Flows Ratio TTM -0.22 63.84 15.88 15.88 18.27 19.2
Price Cash Flow Ratio TTM -0.22 63.84 15.88 15.88 18.27 19.2
Income Statement (TTM)
GCTK ISRG BDXA BDX ALC RMD
Revenue $0B $8.35B $20.18B $20.18B $9.91B $5.15B
Gross Profit $-0B $5.63B $9.13B $9.13B $5.51B $3.05B
Gross Profit Ratio 0% 67.46% 45.22% 45.22% 55.61% 59.36%
EBITDA $-0.02B $2.81B $4.82B $4.82B $2.68B $1.91B
Net Income $0.02B $2.32B $1.71B $1.71B $1.02B $1.4B
EPS Diluted 60.76 6.42 5.86 5.86 2.05 9.51
Balance Sheet (MRQ)
GCTK ISRG BDXA BDX ALC RMD
Long Term Debt $0B $0.11B $18.61B $18.61B $4.97B $0.81B
Total Liabilities $0.02B $2.31B $31.4B $31.4B $8.79B $2.21B
Total Equity $-0.01B $16.53B $25.89B $25.89B $21.55B $5.97B
Total Investments $0B $7.05B $0.45B $0.45B $0.91B $0.09B
Total Debt $0B $0.15B $20.92B $20.92B $5.14B $0.88B
Total Assets $0.01B $18.84B $57.29B $57.29B $30.35B $8.17B
Cash Flow Statement (TTM)
GCTK ISRG BDXA BDX ALC RMD
Net Income $-0.02B $2.34B $1.71B $1.71B $1.02B $1.4B
Inventory $0B $-0.83B $0.1B $0.1B $-0.05B $-0.08B
Dividends Paid $0B $0B $-1.1B $-1.1B $-0.13B $-0.31B
Operating Cash Flow $-0.01B $2.42B $3.8B $3.8B $2.08B $1.75B
Capital Expenditure $-0B $-1.11B $-0.73B $-0.73B $-0.67B $-0.09B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.29
ALC Alcon Inc. 73.89
ANGO AngioDynamics, Inc. 12.03
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 116.01
ATRC AtriCure, Inc. 34.55
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AVTR Avantor, Inc. 11.82
AZTA Azenta, Inc. 30.2
BAX Baxter International Inc. 18.47
BDX Becton, Dickinson and Company 178.71
BDXA Becton, Dickinson and Company 59.24
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 14.94
BLFS BioLife Solutions, Inc. 27.87
COO The Cooper Companies, Inc. 69.91
DXR Daxor Corporation 13.33
EKSO Ekso Bionics Holdings, Inc. 5.39
Unlock